首页> 外文期刊>Pathology International >Malignant tumors in hernia sac: Clinicopathological and immunohistochemical studies of 21 cases at a single institution
【24h】

Malignant tumors in hernia sac: Clinicopathological and immunohistochemical studies of 21 cases at a single institution

机译:Hernia SAC中的恶性肿瘤:单一机构21例临床病理和免疫组化研究

获取原文
获取原文并翻译 | 示例
           

摘要

Malignant tumors presented in hernia sac are very rare and the clinicopathological features are not well studied. We retrospectively reviewed 21 patients with cancers identified in surgically resected hernia sac specimens at our institution, including 14 males and 7 females, with a median age of 65 years (range 35-93). Fourteen patients (66.7%) carried a synchronous or metachronous cancer diagnosis elsewhere and the tumors in hernia sac were proven to be metastasis. Of the remaining seven (33.3%) cases, hernia sac tumors were the initial presentation of malignancy, and a panel of immunohistochemistry markers were applied in combination with clinical information to identify tumor origin. The final classification of all 21 cases was as follows: 11 gastrointestinal tract tumors including 10 adenocarcinomas and 1 gastrointestinal stromal tumor, 5 pancreatobiliary adenocarcinomas and 5 gynecological serous carcinomas. Compared to other tumor types, pancreatobiliary adenocarcinomas were more likely to involve hernia sac as initial presentation before a primary site was identified (P= 0.0307) and had worse survival (P< 0.005). As the first and largest cohort of malignant tumors in hernia sac, our study provides critical data on frequency, distribution, clinicopathological features and applicability of immunohistochemical markers to determine tumor origin in cases with unknown primary.
机译:疝囊内的恶性肿瘤非常罕见,其临床病理特征尚未得到很好的研究。我们回顾性分析了在我们研究所手术切除的疝囊标本中发现的21例癌症患者,包括14名男性和7名女性,中位年龄为65岁(范围35-93岁)。14名患者(66.7%)在其他地方进行了同步或异时癌症诊断,疝囊中的肿瘤被证实为转移。在剩下的7例(33.3%)病例中,疝囊肿瘤是恶性肿瘤的最初表现,一组免疫组织化学标记物结合临床信息应用于确定肿瘤起源。21例患者的最终分类如下:11例胃肠道肿瘤,包括10例腺癌和1例胃肠道间质瘤,5例胰胆管腺癌和5例妇科浆液性癌。与其他肿瘤类型相比,胰胆管腺癌在确定原发部位之前更可能以疝囊为首发症状(P=0.0307),生存率更差(P<0.005)。作为第一个也是最大的疝囊恶性肿瘤队列,我们的研究提供了关于频率、分布、临床病理特征和免疫组织化学标记物的适用性的关键数据,以确定未知原发性肿瘤的起源。

著录项

  • 来源
    《Pathology International》 |2020年第12期|共9页
  • 作者单位

    Univ Rochester Med Ctr Dept Pathol &

    Lab Med 601 Elmwood Ave Box 626 Rochester NY 14642 USA;

    Univ Rochester Med Ctr Dept Pathol &

    Lab Med 601 Elmwood Ave Box 626 Rochester NY 14642 USA;

    Univ Rochester Med Ctr Dept Pathol &

    Lab Med 601 Elmwood Ave Box 626 Rochester NY 14642 USA;

    Univ Rochester Med Ctr Dept Pathol &

    Lab Med 601 Elmwood Ave Box 626 Rochester NY 14642 USA;

    Univ Rochester Med Ctr Dept Pathol &

    Lab Med 601 Elmwood Ave Box 626 Rochester NY 14642 USA;

    Univ Rochester Med Ctr Dept Pathol &

    Lab Med 601 Elmwood Ave Box 626 Rochester NY 14642 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

    hernia sac; immunohistochemistry; malignant tumor; prognosis;

    机译:疝气;免疫组织化学;恶性肿瘤;预后;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号